Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: Analytical techniques and challenges
Authors:
- Lin LiLLLin Li
- Chee-Leong KeeCKChee-Leong Kee
- Xiaowei GeXGXiaowei Ge
- Min-Yong LowMLMin-Yong Low
- Hwee-Ling KohHKHwee-Ling Koh
- 1 January 2014
- journal article
- review article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 87, 176-190
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- The Global Online Sexuality Survey (GOSS): The United States of America in 2011 Chapter II: Phosphodiesterase Inhibitors Utilization Among English SpeakersThe Journal of Sexual Medicine, 2013
- Future development of global regulations of Chinese herbal productsJournal of Ethnopharmacology, 2012
- Identification of a novel sildenafil analogue in an adulterated herbal supplementJournal of Pharmaceutical and Biomedical Analysis, 2012
- Isolation and structural characterization of two tadalafil analogs found in dietary supplementsJournal of Pharmaceutical and Biomedical Analysis, 2012
- Fingerprinting of sildenafil citrate and tadalafil tablets in pharmaceutical formulations via X-ray fluorescence (XRF) spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Identification of a new sildenafil analogue in a health supplementJournal of Pharmaceutical and Biomedical Analysis, 2011
- Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an exampleEnvironmental Health and Preventive Medicine, 2010
- Safety and Quality Assessment of 175 Illegal Sexual Enhancement Products Seized in Red-Light Districts in SingaporeDrug Safety, 2009
- Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplementJournal of Pharmaceutical and Biomedical Analysis, 2008
- Mass spectrometry-based proteomicsNature, 2003